Contrast-Enhanced Mammography-Guided Breast Biopsy: Single-Center Experience.
Journal
AJR. American journal of roentgenology
ISSN: 1546-3141
Titre abrégé: AJR Am J Roentgenol
Pays: United States
ID NLM: 7708173
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
medline:
26
5
2023
pubmed:
2
2
2023
entrez:
1
2
2023
Statut:
ppublish
Résumé
This prospective single-center study enrolled 50 women with 51 contrast-enhanced mammography (CEM)-enhancing lesions that lacked a sonographic or mammographic correlate. Trial participants underwent CEM-guided biopsy. Biopsy was technically successful for 46 lesions and was not performed for five nonvisualized lesions (all nonmass enhancement), yielding a cancellation rate of 9.8%. Mean biopsy time was 16.6 minutes. All biopsies revealed concordant pathology (25 benign, 10 high-risk, 11 malignant). No non-visualized or benign lesion yielded malignancy at follow-up.
Identifiants
pubmed: 36722757
doi: 10.2214/AJR.22.28780
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM